Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens

Fig. 3

Crude and adjusted hospitalization from a non-AIDS defining cause rates and 95% confidence intervals from Poisson regression models according to ETR + PI exposure. *Adjusted on gender and transmission group, geographic origin, age, HCV co-infection status, the nadir CD4 cell count, the CD4 cell count, viral load, AIDS status at baseline, pneumocystis jiroveci prophylaxis, number of previous ARV and centre total follow-up of heavily treated individuals. **Additionnaly adjusted on NRTI and raltegravir use

Back to article page